Mozambique introduces R21 Vaccine, bolstering malaria control efforts

Mozambique Introduces R21 Vaccine, Strengthening Malaria Control Efforts

Maputo – In a significant advancement for malaria prevention, Mozambique has introduced the R21 vaccine, aimed at reducing the high incidence of malaria among children. Malaria remains a critical health challenge in Africa, with one child succumbing to the disease every minute.

Supported by Gavi, the Vaccine Alliance, and co-financed by the Mozambican government, the country has received approximately 800,000 doses of the R21 vaccine. This initiative will target around 300,000 children through Mozambique’s Expanded Programme on Immunization, focusing on 22 districts in Zambézia province. The vaccination schedule includes four doses, with the initial dose administered to children aged 6 to 11 months.

“The launch of the malaria vaccine in Zambezia is a crucial step in combating the disease,” said Dr. Armindo Tiago, Mozambique’s Minister of Health. “Zambezia was selected due to its high malaria burden. Administering the vaccine in four doses aims to significantly reduce severe malaria cases and fatalities.”

The R21 vaccine, recommended by the World Health Organization (WHO), has shown high efficacy, reducing malaria cases by over 66% in children during the first year of follow-up and providing prolonged protection with the fourth dose. Mozambique’s childhood vaccination programme now includes this groundbreaking vaccine, building on the success of the earlier RTS,S vaccine.

Dr. Severin von Xylander, WHO Representative in Mozambique, highlighted the historical significance of this achievement, emphasizing the pioneering research conducted by Mozambican scientists. This effort has positioned Mozambique as a leader in malaria vaccination, now among 11 African nations offering malaria vaccines.

Despite this progress, malaria continues to pose a severe health threat in Africa, accounting for 94% of global malaria cases and 95% of deaths in 2022. Comprehensive prevention strategies, including the distribution of insecticide-treated nets and ongoing community engagement, remain essential in the fight against malaria.

Gavi, UNICEF, WHO, and other partners are actively supporting Mozambique’s Ministry of Health in implementing the vaccine, ensuring community acceptance, and enhancing the health infrastructure required for successful vaccine deployment.